Contact Us | Takeda Oncology Support & Inquiries
Contact Us
Headquarters for Takeda’s Global Oncology Business Unit
40 Landsdowne Street
Cambridge, MA, USA 02139
TEL: +1-617-679-7000
United States Contact Information and Frequently Asked Questions
How do I report suspected side effects or adverse events?
- To report suspected adverse reactions for Oncology products, please call 1-844-662-8532 or email [email protected].
- For non-Oncology products, please call 1-877-TAKEDA7 (1-877-825-3327) or email [email protected].
- You may also report suspected adverse reactions to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
For United States Healthcare Professionals
- For Medical Information Requests on our Products and related Therapeutic Areas, please call 1-844-662-8532, email [email protected] or visit our U.S. Oncology Medical Information Website.
- If you are a U.S. healthcare professional and would like to submit a Medical Information Request, or request a field medical follow-up, please visit our U.S. Oncology Medical Information Website for more information.
How do I submit media related inquiries?
- For media inquiries or reporter requests for more information, contact Oncology Communications via [email protected].
- For other Takeda news releases, please visit the Takeda.com Newsroom.
How do I inquire about partnership opportunities?
- If interested in partnering with Takeda Oncology, please reach out to our team at [email protected].
How do I contact Global Takeda?
- Please visit the Contact Global Takeda page for more information, frequently asked questions and the ability to submit a comment or question to Takeda Pharmaceutical Company Limited.
How do I seek proof of employment?
- For proof of employment or to check the work history of a job candidate, please contact The Work Number at 1-800-367-5690. If you need additional assistance, please contact the Client Service Center at 1-866-604-6572 or 1-800-424-0253 for Hearing Impaired TTy/TTD. Takeda's Employer Code is 13562.
Privacy Notice
If you have any questions about the practices of this website, refer to our Privacy Notice.